pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
rogocekib
rogocekib [INN]
Chronic Myelomonocytic Leukemia (CMML)
Chordia Therapeutics Inc
0 catalysts
Marketed
rolapitant hydrochloride
Varubi (rolapitant hydrochloride)
Chemotherapy Induced Nausea and Vomiting
TerSera Therapeutics LLC
0 catalysts
Marketed
romidepsin
Romidepsin (romidepsin)
Cutaneous T-Cell Lymphoma
Fresenius Kabi USA LLC
0 catalysts
← prev
page 253 of 271
next →
131
Pain89
Neurology1
Phase 3
romiplostim
Nplate (romiplostim)
Thrombocytopenia
Thrombopoietin receptor
$AMGNAMGEN INC
0 catalysts
Phase 3
romosozumab
Evenity (romosozumab-aqqg)
Osteogenesis Imperfecta
Sclerostin
$AMGNAMGEN INC
0 catalysts
Phase 2
rondaptivon pegol
Hemophilia A (Factor VIII Deficiency)
Band Therapeutics LLC
0 catalysts
Phase 2
rondecabtagene autoleucel
rondecabtagene autoleucel [INN]
Diffuse Large B-Cell Lymphoma
$LYELLyell Immunopharma, Inc.
0 catalysts
Phase 2
ropanicant
ropanicant [INN]
Major Depressive Disorder
Suven Life Sciences Ltd
0 catalysts
pre_registration
ropeginterferon alfa-2b LA
Besremi (ropeginterferon alfa-2b [INN])
Essential Thrombocythemia
PharmaEssentia Corp
0 catalysts
Marketed
ropinirole hydrochloride PR
Ropinirole Hydrochloride (ropinirole hydrochloride)
Parkinson's Disease
Sandoz Inc
0 catalysts
Preclinical
ropivacaine
Ropivacaine Hydrochloride (ropivacaine [INN])
Anesthetic Effect
MedinCell SA
0 catalysts
Phase 3
ropivacaine SR
ropivacaine [INN]
Post-Operative Pain
Taiwan Liposome Co Ltd
0 catalysts
Phase 2
rose bengal sodium
rose bengal sodium [INN]
Metastatic Melanoma
$PVCTPROVECTUS BIOPHARMACEUTICALS, INC.
0 catalysts
Phase 2
rosolutamide
rosolutamide [INN]
Kennedy's Disease (Spinal and Bulbar Muscular Atrophy)
Annji Pharmaceutical Co Ltd
0 catalysts
Phase 2
rosopatamab tetraxetan
rosopatamab tetraxetan [INN]
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Convergent Therapeutics Inc
0 catalysts
Phase 3
rostaporfin
Metastatic Breast Cancer
TuHURA Biosciences Inc
0 catalysts
Marketed
rosuvastatin calcium
Rosuvastatin Calcium (rosuvastatin calcium)
Dysbetalipoproteinemia (Type III Hyperlipoproteinemia)
Teva Pharmaceuticals USA Inc
0 catalysts
pre_registration
rotavirus [serotypes G1, G2, G3, G4, G9] (pentavalent) vaccine
Rotarix
Rotavirus Infections
$GSKGSK plc
0 catalysts
Marketed
rotavirus [serotypes G1, G2, G3, G4, P1] (pentavalent) vaccine
RotaTeq
Rotavirus Infections
$MRKMerck & Co., Inc.
0 catalysts
Marketed
rotigotine ER
Neupro (rotigotine)
Parkinson's Disease
UCB SA
0 catalysts
Phase 2
roxadustat
Myelodysplastic Syndrome (Preleukemia)
Hypoxia-inducible factor prolyl hydroxylase
$KYNBKYNTRA BIO, INC.
0 catalysts
Marketed
rufinamide
Banzel (rufinamide)
Lennox-Gastaut Syndrome
Eisai Co Ltd
0 catalysts
pre_registration
rusfertide acetate
Polycythemia Vera
$PTGXProtagonist Therapeutics, Inc
0 catalysts
Phase 2
ruxolitinib phosphate
Jakafi (ruxolitinib phosphate)
Hemophagocytic Lymphohistiocytosis
Tyrosine-protein kinase JAK1Tyrosine-protein kinase JAK2
$INCYINCYTE CORP
0 catalysts
Phase 2
ruxoprubart
Paroxysmal Nocturnal Hemoglobinuria
NovelMed Therapeutics Inc
0 catalysts
Phase 2
ruxotemitide
Oncopore (ruxotemitide [INN])
Metastatic Melanoma
Lytix Biopharma ASA
0 catalysts
Phase 2
sabirnetug
Alzheimer's Disease
$ABOSAcumen Pharmaceuticals, Inc.
0 catalysts
Preclinical
sabizabulin hydrochloride
Ebolavirus Infections (Ebola Hemorrhagic Fever)
$VERUVERU INC.
0 catalysts
Phase 2
sacituzumab drozuntecan
sacituzumab drozuntecan [INN]
Epithelial Ovarian Cancer
$BNTXBioNTech SE
0 catalysts
Phase 3
sacituzumab tirumotecan
Adenocarcinoma Of The Gastroesophageal Junction
$MRKMerck & Co., Inc.
0 catalysts